Atossa Genetics inc.

Atossa Genetics, Inc., the breast health company, is based in Seattle, Washington, and is focused on the prevention of breast cancer through the commercialization of diagnostic medical devices and tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions.

Upcoming Events

May 22, 2013 Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President of Atossa Genetics, will participate in a panel discussion on Diagnostics at the Sachs Cancer Bio Partnering Forum at the Westin Copley Place, Boston, MA

May 22, 2013 Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President of Atossa Genetics, will present at the Sachs Cancer Bio Partnering Forum, at the Westin Copley Place, Boston, MA at 11:00am in the Essex North Room

May 30, 2013 Atossa Genetics to present at the Marcum MicroCap Conference, at the Grand Hyatt Hotel, 109 E 42nd Street, NY, NY

Jun 7, 2013 Atossa Genetics to present at the Sidoti & Co., Micro-Cap Conference at the Grand Hyatt Hotel, 109 E 42nd Street New York, NY

View all events

IR Kit

Corporate Presentation	CEOCFO Magazine Interview with Dr. Steven C. Quay, MD, PhD, FCAP, Chairman, CEO and President, Atossa Genetics Inc., Published – December 24, 2012

Investor Relations

Matthew D. Haines
MBS Value Partners
424 Madison Avenue Suite 400, New York, NY 10017
tel 212-710-9686
fax 212-661-2268
Matt.Haines@mbsvalue.com | www.mbsvalue.com